Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Other Working Capital Changes (2021 - 2025)

Historic Other Working Capital Changes for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$220000.0.

  • Biofrontera's Other Working Capital Changes rose 9544.04% to -$220000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $733000.0, marking a year-over-year increase of 9546.67%. This contributed to the annual value of -$5.2 million for FY2024, which is 20000.0% down from last year.
  • Per Biofrontera's latest filing, its Other Working Capital Changes stood at -$220000.0 for Q3 2025, which was up 9544.04% from $729000.0 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Other Working Capital Changes registered a high of $5.5 million during Q4 2023, and its lowest value of -$4.8 million during Q3 2024.
  • Over the past 5 years, Biofrontera's median Other Working Capital Changes value was -$125000.0 (recorded in 2022), while the average stood at $21555.6.
  • As far as peak fluctuations go, Biofrontera's Other Working Capital Changes crashed by 445421.69% in 2022, and later skyrocketed by 1686969.7% in 2023.
  • Biofrontera's Other Working Capital Changes (Quarter) stood at $4.0 million in 2021, then plummeted by 100.82% to -$33000.0 in 2022, then soared by 16869.7% to $5.5 million in 2023, then tumbled by 187.19% to -$4.8 million in 2024, then surged by 95.44% to -$220000.0 in 2025.
  • Its last three reported values are -$220000.0 in Q3 2025, $729000.0 for Q2 2025, and $224000.0 during Q1 2025.